Immix Biopharma, Inc.'s total assets for Q4 2024 were $22.95M, a decrease of -8.73% from the previous quarter. IMMX total liabilities were $9.70M for the fiscal quarter, a 27.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.